Galderma Publishes its 2024 Annual Report and the Invitation to Its First Annual General Meeting

Contributed by: Business Wire

Logo

Tags

Other Health

Health

Cosmetics

Retail

Pharmaceutical

Annual Report and Annual General Meeting

More Like This

Galderma Publishes Invitation and Agenda for Its 2026 Annual General Meeting

Galderma Shareholders Approve All Annual General Meeting Proposals

Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth

Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency

Galderma Delivers Record Net Sales of 3.259 B USD in the First Nine Months of 2024, Demonstrates Significant Innovation Progress, Confirms and Narrows Its Full Year Net Sales Guidance

Galderma Announces Intention to Float on the SIX Swiss Exchange

Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency1, and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond

Galderma Delivers Record Net Sales of 2.2 Billion USD and 10.8% Year-on-Year Growth at Constant Currency for the First Half of 2024